Stock Ticker

  • Loading stock data...

TrovaGene Inc (NASDAQ:TROV) Strengthens Board With Appointment Of Dr. Athena Countouriotis

TrovaGene Inc (NASDAQ:TROV) reported the strengthening and expansion of its Board with the election of Athena Countouriotis, M.D., who brings extensive experience leading clinical advancement programs, from preclinical through clinical phases, and approval. During the course of her career, Dr. Countouriotis has been involved in numerous clinical plans, with a focus within oncology that have […]

TrovaGene Inc (NASDAQ:TROV) And Novogene Enter Agreement Over Nextcollect

Novogene has revealed that it is entering into a deal with TrovaGene Inc (NASDAQ:TROV), a firm focusing on precision medicine biotechnology with a view to acquiring NextCollect, a proprietary device for nucleic acid preservation and urine collection. Besides selling Nextcollect to Novogene, Trovagene will also sell reagents and methods of extracting from urine cell-free DNA. […]

TrovaGene Inc (NASDAQ:TROV) Collaborates With Global Biopharmaceutical Company Ahead Of Its Cancer Clinical Trials

TrovaGene Inc (NASDAQ:TROV), which happens to be a top end precision medicine biotechnology provider has proceeded to make the much awaited announcement. Through one of its top officials, it revealed that it was going to collaborate with a worldwide, premier biopharmaceutical company, an agreement that would see the two engage in the provision of Trovera® […]

TrovaGene Inc (NASDAQ:TROV) Expands Clinical Trial to Include Precision Cancer Monitoring Platform In Lung Cancer

Boston, MA 09/30/2014 (wallstreetpr) – Development-stage molecular diagnostic company, TrovaGene Inc (NASDAQ:TROV) disclosed that it has expanded its clinical trial program to include precision cancer monitoring platform in lung cancer patients management. Expands Program According to TrovaGene Inc (NASDAQ:TROV)’s statement, the principal aim of the trial expansion was to identify and monitor EGFR alterations in […]

Sign Up To Get Our Latest Stocks Alerts